Livewire Ergogenics

PINK:LVVV USA Drug Manufacturers - Specialty & Generic
Market Cap
$761.59K
Market Cap Rank
#50921 Global
#15637 in USA
Share Price
$0.00
Change (1 day)
-20.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.08
About

LiveWire Ergogenics, Inc., engages in the development and marketing of handcrafted cannabis-based and hemp-derived products for medical and recreational use in the United States. It is also involved in developing and licensing cannabinoid-based specialty products and services under the SOL VIDA Wellness and Estrella Weedery brand names. LiveWire Ergogenics, Inc. is based in Anaheim, California.

Livewire Ergogenics (LVVV) - Total Liabilities

Latest total liabilities as of September 2025: $4.16 Million USD

Based on the latest financial reports, Livewire Ergogenics (LVVV) has total liabilities worth $4.16 Million USD as of September 2025.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Livewire Ergogenics - Total Liabilities Trend (2008–2024)

This chart illustrates how Livewire Ergogenics's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Livewire Ergogenics Competitors by Total Liabilities

The table below lists competitors of Livewire Ergogenics ranked by their total liabilities.

Liability Composition Analysis (2008–2024)

This chart breaks down Livewire Ergogenics's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.13 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -2.71 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.17 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Livewire Ergogenics's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Livewire Ergogenics (2008–2024)

The table below shows the annual total liabilities of Livewire Ergogenics from 2008 to 2024.

Year Total Liabilities Change
2024-12-31 $4.70 Million +1.69%
2023-12-31 $4.62 Million +8.93%
2022-12-31 $4.24 Million +17.57%
2021-12-31 $3.61 Million -9.47%
2020-12-31 $3.99 Million +28.44%
2019-12-31 $3.10 Million +59.51%
2018-12-31 $1.95 Million +71.79%
2017-12-31 $1.13 Million +4.86%
2016-12-31 $1.08 Million +6.07%
2015-12-31 $1.02 Million +2.48%
2014-12-31 $993.58K +19.93%
2013-12-31 $828.44K -13.70%
2012-12-31 $959.98K +7.95%
2011-12-31 $889.24K +4481.12%
2009-12-31 $19.41K -69.11%
2008-12-31 $62.83K --